Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
Aberrant crypt foci (ACF), the earliest neoplastic lesions of the colon, have genetic and epigenetic alterations. Loss of heterozygosity (LOH) of tumor suppressor gene loci is seen in most colon cancers, but it is not known how early in tumorigenesis this takes place. Nine microsatellite markers close to specific genes, that is, APC (5q21), PTPRJ (11p11), p53 (17p13) and DCC (18q21), were analyzed in 32 ACF and samples of normal crypts from the same 28 patients. Six losses of heterozygosity were found in 5 of 32 ACF: 4 losses of heterozygosity were at 11p11, the location of the gene for protein tyrosine phosphatase receptor type J (PTPRJ) and of a second independent region of deletion; the others were at 5q21 and 18q21. Microsatellite instability (MSI) with markers for a single locus was found in 4 of 32 ACF. All the observed allelic alterations (LOH and MSI) were in 8 of 32 ACF. The finding of LOH in ACF with normal expressions of adenomatous polyposis coli (APC) and beta-catenin proteins suggests that LOH can occur very early in colon neoplasia and perhaps even before APC mutations. The finding of 3 of 4 of the losses of heterozygosity at 11p11 for PTPRJ and half of all the losses of heterozygosity in this study at PTPRJ suggest that this gene plays a role early in colon neoplasia.
Luo
Liping
L
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
Shen
Gong-Qing
GQ
Stiffler
Karen A
KA
Wang
Qing K
QK
Pretlow
Thomas G
TG
Pretlow
Theresa P
TP
D011125:Adenomatous Polyposis Coli / Q000235:genetics*; D000483:Alleles; D002880:Chromosomes, Human, Pair 11; D003110:Colonic Neoplasms / Q000235:genetics*; D015179:Colorectal Neoplasms / Q000473:pathology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D019656:Loss of Heterozygosity; D018895:Microsatellite Repeats / Q000235:genetics; D009154:Mutation; D016133:Polymerase Chain Reaction; D011230:Precancerous Conditions / Q000473:pathology; D051176:beta Catenin / Q000378:metabolism
D051176:beta Catenin